C12N 2710/20032
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2710/20032 (Use of virus as therapeutic agent, other than vaccine) appears on 13 US grants and 18 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 18
- Assignees
- 20
- Inventors
- 37
- Latest grant
- 27 Oct 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 2 |
| 2007 | 1 | 1 |
| 2008 | 3 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 2 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 3 |
| 2020 | 2 | 1 |
By publication year.
Recent patents
- Papillomavirus pseudoviruses for detection and therapy of tumors27 Oct 2020US 10,814,014 B2The USA, as represented by the Secretary, Dept. of Health and Human Services
- Immunomodulating composition for treatment24 Mar 2020US 10,596,248 B2Jingang Medicine (Australia) Pty Ltd
- Papillomavirus pseudoviruses for detection and therapy of tumors29 Jan 2019US 10,188,751 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Polynucleotides for treating oncogenic viral polypeptide positive tumors15 May 2018US 9,969,779 B2Sanford Health
- Polynucleotides for treating oncogenic viral polypeptide positive tumors15 Nov 2016US 9,492,526 B2Sanford Health
- Efficient cell free production of papillomavirus gene transfer vectors9 Jan 2020US 2020/0010850 A1The USA, as represeented by the Secretary, Dept. of Health and Human Services
- Papillomavirus Pseudoviruses for Detection and Therapy of Tumors26 Sep 2019US 2019/0290782 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Augmentation of Oncolytic Viral Efficacy through Immunological Targeting Tumor Endothelial Cells22 Aug 2019US 2019/0255127 A1Batu Biologics, Inc.
- Immunomodulating composition for treatment9 May 2019US 2019/0134181 A1Admedus Vaccines Pty Ltd.
- Polynucleotides for treating oncogenic viral polypeptide positive tumors23 Aug 2018US 2018/0237477 A1Sanford Health
Most cited
By later US patents
- Papillomavirus pseudoviruses for detection and therapy of tumors23US 8,394,411 B2The United States of America as represented by the Secretary, Dept. of Health and Human Services National Institutes of Health · 2013
- Molecular vaccine linking intercellular spreading protein to an antigen10US 7,318,928 B2The Johns Hopkins University · 2008
- Human papillomavirus polypeptides and immunogenic compositions6US 7,223,408 B2Wyeth Holdings Corporation · 2007
- Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors2US 7,374,767 B2Centro de Ingenieria Genetica Y Biotechologia · 2008
- Papillomavirus pseudoviruses for detection and therapy of tumors2US 8,999,290 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2015